Katherine R. Tuttle, MD, FASN, FACP, FNKF is Executive Director for Research at Providence Inland Northwest Health, Regional Principal Investigator of the Institute of Translational Health Sciences and Professor of Medicine at the University of Washington. Dr. Tuttle’s major research interests are in diabetes and chronic kidney with over 350 original peer-reviewed publications. She leads the Center for Kidney Disease Research, Education and Hope (CURE-CKD) Registry of real-world data for chronic kidney disease, diabetes, prediabetes, and hypertension from over 5 million health system patients. Dr. Tuttle is also Chair of the Diabetic Kidney Disease Collaborative for the American Society of Nephrology.

Anthony Good, DNP, MSN, MBA, APRN, FNP-BC, GNP-BC, RN joined the faculty at St. Francis in 2021 as the Program Director, MSN Family (Individual Across the Lifespan) Nurse Practitioner and Program Director Family (Individual Across the Lifespan) Post-Master’s Certificate. He has practiced as a nurse practitioner in primary care, urgent care and nephrology. He continues to maintain active practice at Advanced Kidney Care Medical Associates, Pittsburgh, Pennsylvania. He has been a faculty member for more than 10 years and his research interests include simulation, quality of life and care satisfaction.

Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES is the Allen I. White Distinguished Professor in the College of Pharmacy and Pharmaceutical Sciences at Washington State University (WSU). He served as Chair of the ADA’s (American Diabetes Association) Professional Practice Committee from 2018-2019, whose primary responsibility is updating the ADA’s Standards of Care in Diabetes each year. Josh is currently President Elect for Health Care & Education at ADA and is co-Editor for the ADA’s Guide to Medications for the Treatment of Diabetes Mellitus. In addition to his work at WSU, Josh holds a research appointment with Providence Medical Research Center in Spokane, Washington and is an investigator with the Center for Kidney Disease Research, Education and Hope (CURE-CKD).

Michael J. Blaha MD, MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. He is also the Director of the Cardiometabolic Clinic at Johns Hopkins.

Richard E. Pratley, MD serves as the Samuel E. Crockett Chair in Diabetes Research, Senior Investigator and Diabetes Program Lead at the AdventHealth Translational Research Institute, and Medical Director at the AdventHealth Diabetes Institute, in Orlando, Florida. He is also Adjunct Professor of Medicine at the Johns Hopkins University School of Medicine. Dr. Pratley is an internationally recognized expert in diabetes. He lectures frequently, has conducted numerous research studies on the pathogenesis, prevention and treatment of diabetes, and has published over 300 peer-reviewed articles on diabetes and its complications.

Jorge Plutzky, MD is the Director of Preventive Cardiology in the Cardiovascular Division at Brigham and Women’s Hospital (BWH) and on the faculty of Harvard Medical School. Dr. Plutzky’s clinical interests have focused on preventing all manifestations of cardiovascular disease, with a particular interest in the intersection between abnormal metabolism, like obesity, dyslipidemia and diabetes and cardiovascular health. The current Chair of the AHA’s Diabetes Committee and the recipient of numerous awards for teaching and research, he is also the principal investigator of an NIH-funded basic science laboratory investigating mechanisms of cardio-metabolic disorders.

Neha J. Pagidipati, MD, MPH is an Assistant Professor of Medicine and cardiovascular disease prevention specialist.  Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management.  She is also building the Duke Cardiometabolic Disease Prevention Program, which focuses on behavior change and risk factor management in patients with high risk of cardiovascular and metabolic diseases such as diabetes and obesity.